A new lawsuit challenges medical marijuana licensing in Illinois, claiming that the state failed to follow its own requirements for deciding who would get to grow and sell the drug.
In response, Gov. Bruce Rauner’s administration agreed that the evaluation process started by former Gov. Pat Quinn’s office was flawed, and pledged to cooperate with any court review of the program.
“We understood and acknowledged that the process the Quinn administration applied would likely expose the State to significant and costly litigation,” Rauner’s office stated in an email. “We believe the steps we took to fix the errors in the Quinn selection process reduce, but cannot entirely eliminate, the risk of litigation.
“We will fully participate in any judicial review of the selection process and comply with any orders issued by a court as it relates to this particular applicant or any other applicant that seeks a judicial review,” the statement said. [Read more at the Chicago Tribune]
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
Notify me of follow-up comments by email.
Notify me of new posts by email.
PRESS RELEASE The largest industry trade show in the state September 9-10 at the Atlantic City Convention Center Atlantic City, NJ – NECANN’s 3rd annual New Jersey Cannabis Convention will be returning to the Atlantic City Convention Center September 9-10, 2022. As the largest B2B industry event in the state, the convention serves as an…
Far & Dotter, the franchise business launched last year by Maryland-based Curio Wellness as part of its retail rebrand, announced this week that it has signed its first franchisees out of over 800 reported applications. “The inaugural class of franchisees include Sederia Gray (Mississippi) and Haider Rizvi (New Jersey),” said the company in a prepared…
COLUMBIA Care has confirmed to BusinessCann that it is set to ‘wind down’ its operations across the UK and Europe as its upcoming $2bn takeover by Cresco Labs nears its final stages. The US cannabis giant, which currently has a market cap of around $700m, will pull its products from sale in the UK at…
By Hilary Bricken, Principal at Harris Bricken I get asked a lot of questions about what California cannabis licensees can and cannot do under the Medicinal and Adult-Use Cannabis Regulation and Safety Act (“MAUCRSA”). California is actually business friendly once operations get going with a license– despite its many issues with the cannabis industry. For…